TY - JOUR
T1 - Predictors of Clinical Success after Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort
AU - Morisaki, Mitsuha
AU - Kurihara, Isao
AU - Itoh, Hiroshi
AU - Naruse, Mitsuhide
AU - Takeda, Yoshiyu
AU - Katabami, Takuyuki
AU - Ichijo, Takamasa
AU - Wada, Norio
AU - Yoshimoto, Takanobu
AU - Ogawa, Yoshihiro
AU - Sone, Masakatsu
AU - Tsuiki, Mika
AU - Shibata, Hirotaka
AU - Kawashima, Junji
AU - Fujita, Megumi
AU - Watanabe, Minemori
AU - Matsuda, Yuichi
AU - Kobayashi, Hiroki
AU - Suzuki, Tomoko
N1 - Publisher Copyright:
Copyright © 2019 Endocrine Society.
PY - 2019/11
Y1 - 2019/11
N2 - Context: Aldosterone-producing adenomas are a curable subtype of primary aldosteronism (PA); however, hypertension persists in some patients after adrenalectomy. Objective: To identify factors associated with, and develop prediction models for, blood pressure (BP) normalization or improvement after adrenalectomy. Design: Retrospective analysis of patients treated between 2006 and 2018, with a 6-month follow-up. Setting: A nationwide, 29-center Japanese registry encompassing 15 university hospitals and 14 city hospitals. Patients: We categorized 574 participants in the Japan Primary Aldosteronism Study, who were diagnosed with PA and underwent adrenalectomy, as BP normalized or improved, on the basis of their presentations at 6 months postsurgery. Main Outcome Measure: The rate of complete, partial, and absent clinical success. Predictive factors related to BP outcomes after PA surgery were also evaluated. Results: Complete clinical success was achieved in 32.6% and partial clinical success was achieved in 53.0% of the patients at 6 months postsurgery. The following five variables were independent predictors for BP normalization: ≤7 years of hypertension, body mass index ≤25 kg/m2, no more than one antihypertensive medication, absence of medical history of diabetes, and female sex. The area under the receiver operator characteristic curve was 0.797 in the BP normalization model. Conclusion: We established models that predicted postoperative BP normalization in patients with PA. These should be useful for shared decision-making regarding adrenalectomy for PA.
AB - Context: Aldosterone-producing adenomas are a curable subtype of primary aldosteronism (PA); however, hypertension persists in some patients after adrenalectomy. Objective: To identify factors associated with, and develop prediction models for, blood pressure (BP) normalization or improvement after adrenalectomy. Design: Retrospective analysis of patients treated between 2006 and 2018, with a 6-month follow-up. Setting: A nationwide, 29-center Japanese registry encompassing 15 university hospitals and 14 city hospitals. Patients: We categorized 574 participants in the Japan Primary Aldosteronism Study, who were diagnosed with PA and underwent adrenalectomy, as BP normalized or improved, on the basis of their presentations at 6 months postsurgery. Main Outcome Measure: The rate of complete, partial, and absent clinical success. Predictive factors related to BP outcomes after PA surgery were also evaluated. Results: Complete clinical success was achieved in 32.6% and partial clinical success was achieved in 53.0% of the patients at 6 months postsurgery. The following five variables were independent predictors for BP normalization: ≤7 years of hypertension, body mass index ≤25 kg/m2, no more than one antihypertensive medication, absence of medical history of diabetes, and female sex. The area under the receiver operator characteristic curve was 0.797 in the BP normalization model. Conclusion: We established models that predicted postoperative BP normalization in patients with PA. These should be useful for shared decision-making regarding adrenalectomy for PA.
KW - cure
KW - hypertension
KW - improvement
KW - predictive model
KW - primary aldosteronism
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85077780017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077780017&partnerID=8YFLogxK
U2 - 10.1210/js.2019-00295
DO - 10.1210/js.2019-00295
M3 - Article
AN - SCOPUS:85077780017
SN - 2472-1972
VL - 3
SP - 2012
EP - 2022
JO - Journal of the Endocrine Society
JF - Journal of the Endocrine Society
IS - 11
ER -